Knowledge Tree
Relations (1)
related 2.32 — strongly supporting 13 facts
Anxiety is frequently studied as a comorbid psychological symptom in patients with cancer, as evidenced by clinical reviews and guidelines evaluating interventions like biofeedback [1], mindfulness [2], relaxation therapies [3], and hypnosis [4] to manage these symptoms.
Facts (13)
Sources
Ancient Roots of Today's Emerging Renaissance in ... link.springer.com 3 facts
referenceSchmidt (2016) conducted a randomized controlled trial demonstrating that psilocybin treatment leads to rapid and sustained symptom reduction in patients with life-threatening cancer suffering from anxiety and depression.
referenceCharles A. Grob, Alicia L. Danforth, Gurpreet S. Chopra, Marycie Hagerty, Charles R. McKay, Adam L. Halberstadt, and George R. Greer published the 'Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer' in the Archives of General Psychiatry in 2011.
referenceRoland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P. Cosimano, and Margaret A. Klinedinst published the study 'Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial' in the Journal of Psychopharmacology in 2016.
Mind and Body Approaches for Stress and Anxiety - nccih nccih.nih.gov 3 facts
claimThe 2023 joint guideline issued by the Society for Integrative Oncology and the American Society for Clinical Oncology recommends that hypnosis may be offered to people with cancer to improve anxiety symptoms during cancer-related diagnostic and treatment procedures, with an intermediate quality of evidence and a moderate strength of recommendation.
measurementA 2019 analysis of 29 studies involving 3,274 participants showed that mindfulness-based practices significantly reduced psychological distress, fatigue, sleep disturbance, pain, and symptoms of anxiety and depression among people with cancer, though the results may not generalize to other populations due to the study sample being primarily women with breast cancer.
referenceIn a 2023 joint guideline, the Society for Integrative Oncology and the American Society for Clinical Oncology recommended that relaxation therapies may be offered to adults with cancer to improve anxiety symptoms during active treatment, citing intermediate quality of evidence and moderate strength of recommendation.
What is Inflammation? Causes, Effects, Treatment - Harvard Health health.harvard.edu 2 facts
claimChronic, low-grade inflammation is associated with an increased risk of cardiovascular disease, cancer, type 2 diabetes, Alzheimer's disease, allergies, asthma, arthritis, anxiety, depression, and certain skin conditions.
claimChronic inflammation contributes to several major health conditions, including cardiovascular disease, cancer, type 2 diabetes, Alzheimer's disease, allergies, asthma, arthritis, anxiety, depression, and certain skin conditions.
Mind and Body Approaches for Stress and Anxiety frontlineerdallas.com 1 fact
measurementA 2018 systematic review of 9 studies with 278 total participants found that while biofeedback for anxiety and depression in children and adolescents with long-term physical conditions (such as chronic pain, asthma, cancer, and headache) appears promising, it cannot currently be recommended for clinical use in place of or in addition to current treatments.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua 1 fact
claimStephen Ross et al. conducted a randomized controlled trial showing rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer, published in the Journal of Psychopharmacology, volume 30, page 1165.
Classification Schemes of Altered States of Consciousness - ORBi orbi.uliege.be 1 fact
claimRoss et al. (2016) conducted a randomized controlled trial demonstrating that psilocybin treatment leads to rapid and sustained symptom reduction for anxiety and depression in patients with life-threatening cancer.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 1 fact
referenceRoss, Bossis, Guss, Agin-Liebes, Malone, Cohen, et al. published 'Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial' in the Journal of Psychopharmacology in 2016 (doi: 10.1177/0269881116675512).
Published Studies — Johns Hopkins Center for Psychedelic and ... hopkinspsychedelic.org 1 fact
claimPsilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer, as demonstrated in a randomized double-blind trial.